Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
A Standard patent application filed on 17 March 2000 credited to Stirling, David
;
Muller, George W.
Details
Application number :
37550
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
Inventor :
Stirling, David
;
Muller, George W.
Agent name :
PIZZEYS
Address for service :
GPO Box 1374 BRISBANE QLD 4001
Filing date :
17 March 2000
Associated companies :
Applicant name :
Celgene Corporation
Applicant address :
86 Morris Avenue Summit NJ 07901 United States Of America